secwatch / observer
8-K filed February 27, 2024, 6:59 PM ET ticker ALHC CIK 0001832466
earnings confidence high sentiment neutral materiality 0.60

Alignment Healthcare reports Q4 2023 revenue $465M, up 28.6% YoY; guides FY2024 EBITDA breakeven at midpoint

Alignment Healthcare, Inc.

2023-FY EPS reported -$0.79 revenue$1,823,630,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Alignment Healthcare, Inc. reported fourth quarter ended December 31, 2023 results: revenue $465.4 million, net income $(47.2) million. Guidance initiated.

Period
fourth quarter ended December 31, 2023
Revenue
$465.4 million
Net income
$(47.2) million
Guidance
initiated
Result
reported results
Exact text from the filing
Health plan membership at the end of the quarter was approximately 119,200, up 21.1% year over year Total revenue was $465.4 million, up 28.6% year over year Health plan premium revenue of $459.0 million represented 27.5% growth year over year Adjusted gross profit was $49.2 million and loss from operations was ($41.9) million Adjusted gross profit excludes depreciation and amortization of $5.9 million and selling, general, and administrative expenses of $83.7 million (which includes $14.1 million of equity-based compensation). Adjusted gross profit also excludes an additional $1.5 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 89.4% Adjusted EBITDA was ($19.7) million and net loss was ($47.2) million
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Alignment Healthcare, Inc. reported full year ended December 31, 2023 results: revenue $1,823.6 million, net income $(148.2) million. Guidance initiated.

Period
full year ended December 31, 2023
Revenue
$1,823.6 million
Net income
$(148.2) million
Guidance
initiated
Result
reported results
Exact text from the filing
Total revenue was $1,823.6 million, up 27.2% year over year Health plan premium revenue of $1,800.9 million represented 25.8% growth year over year Adjusted gross profit was $208.8 million and loss from operations was ($127.8) million Adjusted gross profit excludes depreciation and amortization of $21.7 million and selling, general, and administrative expenses of $307.4 million (which includes $59.3 million of equity-based compensation). Adjusted gross profit also excludes an additional $7.5 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 88.5% Adjusted EBITDA was ($35.3) million and net loss was ($148.2) million
View on SEC.gov

39 earnings releases filed in the last 30 days. Browse all earnings releases →

Alignment Healthcare, Inc. filing history →

Source: SEC EDGAR
accession 0001171843-24-001014
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.